Given the combination of different regulatory paths that RKIP engages with to negatively influence the expression of a variety of MMPs, it is likely that targeted suppression of RKIP expression in cancers plays a major role in facilitating the cancer’s ability to upregulate MMP expression and further modulate its TME to produce favorable and proliferative conditions. Here, PEBP1 is linked to cancer.